Quick answers
- What is Iopidine 1%?
- Iopidine 1% is a brand name of Apraclonidine hydrochloride ophthalmic solution, a prescription medicine. The FDA NDC Directory lists 1 Iopidine 1% product in 1 strength and form.
- Who makes Iopidine 1%?
- Harrow Eye holds the FDA application for Iopidine 1% (NDA019779, approved December 31, 1987).
- Is there a generic or store brand of Iopidine 1%?
- Other products of Apraclonidine hydrochloride ophthalmic solution are listed with the FDA, but none in exactly the same strength and form as a Iopidine 1% product.
- Has Iopidine 1% been recalled?
- No recall linked to Iopidine 1% products (by their NDC code or label) appears in the FDA enforcement reports we use.
What Iopidine 1% is
Each Iopidine 1% product as listed in the FDA NDC Directory, by active ingredient, strength and form, with its official label. “Same medicine, other names” counts the other products with exactly the same active ingredients, strength and form (generic versions, store brands and other brands); inactive ingredients can differ.
Apraclonidine hydrochloride ophthalmic solution · prescription medicine
| Strength and form | Product names | Same medicine, other names | Label |
|---|---|---|---|
| apraclonidine hydrochloride 10 mg/mL solution/ drops (ophthalmic) | Iopidine 1% | None listed | DailyMed |
Its page lists every product and company, the FDA label’s uses and boxed warning, approvals, shortages and recalls: Apraclonidine hydrochloride ophthalmic solution →
FDA approval
- NDA: New Drug Application: how a new (usually brand-name) medicine is approved.
| Application | Holder | First approved | Products |
|---|---|---|---|
| NDA019779 | Harrow Eye | December 31, 1987 | 1 |
Companies that list Iopidine 1%
The company named on the package (holder, repackager or distributor), as listed in the FDA NDC Directory, with its number of Iopidine 1% products.
- Harrow Eye, LLC1 product
Recalls
No recall linked to Iopidine 1% products (by their NDC code or label) appears in the FDA enforcement reports.
Sources
- NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug labeling (SPL, openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026
- NADAC (National Average Drug Acquisition Cost) 2026 — Centers for Medicare & Medicaid Services (CMS), data.medicaid.gov, list of November 4, 2026, retrieved November 7, 2026
Which names get a brand page: a name the NDC Directory lists for a medicine, held by one company (the FDA application holder, or the company named on most of its products), that is not just a description, and that is not the only product of its medicine.